Clinical Trial Update: Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial evaluating two dosing schedules of perifosine in patients with solid tumors or lymphomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Tumors, Lymphomas | Phase 2 | Status: COMPLETED